Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [IR] SK hynix (000660 / SKHY) – Q2 2025 Earnings Presentation / 2025-07-24 IR Room
  • [Research] SK hynix (000660 / SKHY) – Hana | HBM4 · LTA · Valuation Appeal / 2026-07-30 Research
  • [IR] Samsung Electronics (005930) – Q1 2024 Earnings Presentation / 2024-04-30 IR Room
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Medium- to Long-Term Growth / 2026-05-11 Research
  • [Research] LIG D&A (079550) – Hana Securities | 4Q25 Miss · Solid Order Backlog · Medium-to-Long-term Fundamentals / 2026-02-19 Research
  • [Research] ABL Bio (298380) – Kiwoom Securities | ABL301 Deprioritization · ABL001 Valuation · Grabody B Validity / 2026-02-02 Research
  • [Research] SK hynix (000660 / SKHY) – Kyobo | Agentic AI · High-Value Memory · Pricing Momentum / 2026-04-24 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Commodity DRAM Pricing · LTA · Multiple Expansion / 2026-06-26 Research

[Research] Samsung SDI (006400) – SK Securities | Plant Utilization Recovery · North America ESS Expansion · AMPC Benefits / 2026-04-29

Posted on April 29, 2026August 22, 2026 By ksb220805@gmail.com

Brokerage : SK Securities

Analyst : Hyung-wou Park

Investment Rating : BUY (Maintained)

Target Price : KRW 810,000 (Raised)

Core Momentum : Building a sequential earnings recovery path led by expanding North American ESS capacity, rising utilization rates (1Q 45% → 2H 65%), new EV program shipments, and higher AMPC recognition.

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: BUY (Maintained), Target Price KRW 810,000 (Raised by applying a historical upcycle average P/B multiple of 3.0x from 2021–2022 to 2026F BPS)
  • Market Data (As of 2026-04-28): Current Price KRW 680,000 (Upside Potential 19.1%), Market Cap KRW 54.80 Trillion, Shares Outstanding 80.59 Million, Foreign Ownership 25.35%
  • 2026 Full-Year Forecasts (New Estimates vs Consensus):
    • Revenue: KRW 16.07 Trillion (+6% vs consensus KRW 15.11 Trillion)
    • Operating Profit: KRW -2.0 Billion (Loss narrowed vs consensus KRW -383.0 Billion)
    • Net Profit (Controlling): KRW 375.0 Billion (+195% vs consensus KRW 127.0 Billion)
  • Valuation Insight: The current 2026F P/B multiple of 2.5x leaves meaningful upside potential relative to historical levels and global peers.

🚀 2. [Market Opportunities & Business Outlook]

  • 1Q26 Earnings Review: Operating loss stood at KRW -155.6 Billion (Loss narrowed YoY), beating market expectations (KRW -257.6 Billion) by approximately KRW 100.0 Billion. Around half of the beat stemmed from OEM compensation, while the remainder was driven by higher small battery sales and margin improvement in UPS-centric ESS. Total AMPC recognized was KRW 80.5 Billion (EV KRW 40.2 Billion, ESS KRW 40.3 Billion). Real EV shipments grew slightly after excluding one-off compensation.
  • 2026 Growth Drivers (Three Core Pillars):
    • ESS Segment: 2Q revenue is projected to grow over 10% QoQ. Full-year growth will accelerate through North American capacity expansion (full-year NCA 7GWh operations + LFP 12GWh mass production starting 4Q26).
    • Small Batteries: Continued recovery in power tools and rising BBU demand for data centers (2026 full-year BBU revenue estimated in the low-to-mid KRW 600 Billion range).
    • EV & Utilization Rates: Muted through 1H26, but set to rebound in 2H26 on new model shipments starting in June and AMPC expansion. Overall plant utilization is expected to improve sequentially from 40–50% in 1Q26 to 60–70% in 2H26.
    • 2026 Full-Year AMPC Projection: KRW 469.1 Billion (EV KRW 193.0 Billion, ESS KRW 276.1 Billion).

📝 Editor’s Comment (Perspective)

The analyst views Samsung SDI as a battery manufacturer navigating through cyclical EV downturns by expanding North American ESS capacity, capturing BBU small-battery demand, and executing a gradual recovery in factory utilization (from 40–50% in 1Q to 60–70% in 2H). This perspective places primary importance on operational leverage from rising plant utilization and policy-driven AMPC earnings generation in North America, rather than near-term losses in pure EV automotive segments.

To track the ongoing validity of this investment thesis, key monitoring factors include the commercial launch and yield stabilization of the US LFP ESS line (12GWh) in 4Q26, the tangible recovery of company-wide plant utilization toward the 60–70% range in 2H26, and the actual quarterly realization of the projected KRW 469.1 Billion in annual AMPC credits. These execution milestones can be verified through upcoming quarterly earnings releases, official IR presentations, and periodic regulatory filings.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, EV & Battery

Post navigation

Previous Post: [Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28
Next Post: [Research] Samsung SDI (006400) – Kyobo Securities | AI Data Center BBU · Direct CSP Channels · 1Q Earnings Beat / 2026-04-29

Related Posts

  • [Research] Alteogen (196170) – Daishin Securities | Keytruda Qlex Commercial Milestones · RNA Modality Expansion · Platform Re-rating / 2026-08-10 Research
  • [Research] Alteogen (196170) – Shinhan Securities | GSK Deal Supports Low Patent Risk View · Keytruda SC Royalty Calibrated · Target Price Adjusted / 2026-01-21 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Capex Discipline · Multi-Year LTA · Shareholder Returns / 2026-01-30 Research
  • [Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28 Research
  • [Research] Samsung SDI (006400) – Hanwha Investment & Securities | Sequential Segment Recovery · Order Pipeline Visibility · Form Factor Diversification / 2026-04-29 Research
  • [Research] Hanwha Ocean (042660) – Shinhan | Merchant Profit Level-Up · Special Ship Order Variables · Balanced Portfolio / 2026-07-28 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Cash Flow · Shareholder Returns / 2026-01-30 Research
  • [Research] Samsung Biologics (207940) – Shinhan Securities | Rockville Revenue Recognition · Guidance Revision Potential · Songdo Plant 6 Groundbreaking / 2026-04-23 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23 Research
  • [Research] LIG D&A (079550) – Shinhan Securities | 4Q25 One-off Shock · KRW 26.2T Backlog · Long-term Structural Growth / 2026-02-20 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | US Operations · Plant 5 Ramp-up · Peptide Expansion / 2026-07-24 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | Profit Turnaround · ESS Margin Support · North America LFP Ramp-up / 2026-07-20 Research
  • [IR] SK hynix (000660 / SKHY) – Q2 2024 Earnings Presentation / 2024-07-25 IR Room
  • [Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme